Cambridge biotech in talks for big Seaport move
If the deal goes through, the company would become the largest life-sciences tenant to relocate from Cambridge to the Seaport since Vertex Pharmaceuticals moved to Fan Pier five years ago. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 22, 2019 Category: Pharmaceuticals Authors: Catherine Carlock Source Type: news

What now for Alzheimer’s research after drug failure?
Biogen’s aducanumab was last hope of one approach to the disease, but there are others (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 22, 2019 Category: Pharmaceuticals Source Type: news

Can Drinking Very Hot Tea Raise Your Risk Of Esophageal Cancer?
A study showed that drinking tea above this temperature was associated with higher esophageal cancer rates. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Another Promising Alzheimer ’ s Drug Trial Ends In Failure: ‘ This One Hurts ’
(CNN) — It’s another devastating blow in the search for a treatment for patients living with Alzheimer’s disease. Pharmaceutical giant Biogen and its Japanese partner Eisai announced Thursday they were halting two phase three clinical trials of a drug that targets the buildup in the brain of beta-amyloid, one of two proteins that researchers believe contribute to the development of Alzheimer’s. The drug, called aducanumab, was the most promising candidate in a field that has been littered with failures. It was so promising that the company was running two phase three trials simultaneously, said neur...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 21, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Alzheimer's Disease CNN Source Type: news

Recent Increase Reported in Drug Overdose Deaths Involving Fentanyl
THURSDAY, March 21, 2019 -- From 2011 to 2016, there was an increase in drug overdose deaths involving fentanyl, according to the March 21 National Vital Statistics Reports, a publication from the U.S. Centers for Disease Control and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Cannabidiol Products Now Available at Hundreds of CVS Stores
THURSDAY, March 21, 2019 -- Creams, sprays, and lotions infused with the nonintoxicating hemp component cannabidiol (CBD) are now being sold at more than 800 CVS stores in eight states. The products will be sold in store aisles, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves New Device for Chronic, Moderate-to-Severe Heart Failure
THURSDAY, March 21, 2019 -- The Optimizer Smart system was approved for treatment of patients with chronic, moderate-to-severe heart failure who are not eligible for treatment with other heart failure devices, including cardiac resynchronization... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

DG/health NATURALS Cough Syrup & #43; Mucus for Infants Recalled
THURSDAY, March 21, 2019 -- One lot of DG/health NATURALS baby Cough Syrup + Mucus is being recalled due to possible contamination with potentially harmful bacteria, says maker Kingston Pharma, LLC. The recall is for Lot KL180157 of 2-fl oz (59 mL)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Certain Dietary Patterns Linked to Cognitive Performance
THURSDAY, March 21, 2019 -- Higher Mediterranean diet (MedDiet) and A Priori Diet Quality Score (APDQS) scores are associated with better cognitive performance in midlife, according to a study published online March 6 in Neurology. Claire T. McEvoy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Biogen shares slump on Alzheimer’s drug trial failure
Drugmaker loses $18bn from market value after deciding to discontinue trials (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 21, 2019 Category: Pharmaceuticals Source Type: news

Aspirin: Have the New Guidelines Changed What You Should Do?
For many people without evidence of cardiovascular disease, less will be more – with the benefit of aspirin just not worth the risk and inconvenience – and that is particularly true for those older than 70 years or with an increased risk of bleeding. And that fits just fine with the new guidelines. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Harlan Krumholz, Contributor Source Type: news

Theranos Is A Cautionary Tale For European Deeptech: Staring Our Complicity In The Face
With the release of Alex Gibney's new Theranos documentary'The Inventor', deeptech startup audiences in Europe must realise that we must accept our own role in the propagation of hype, and ensure we stare our complicity in the face if we're to futureproof against the European Elizabeth Holmes. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Gemma Milne, Contributor Source Type: news

Sonendo(R) Announces Three Key Hires
LAGUNA HILLS, Calif., March 21, 2019 /PR Newswire/ – Sonendo, a market-leading dental technology company, and developer of the GentleWave® System announced today three new additions to its leadership team in support of its rapid commercial growth. T... Devices, Dental, Personnel Sonendo, GentleWave, endodontic therapy, root canal therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2019 Category: Pharmaceuticals Source Type: news

RegeneRx Announces New Board Member
ROCKVILLE, Md., March 21, 2019 -- (Healthcare Sales & Marketing Network) -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair a... Biopharmaceuticals, Personnel RegeneRx Biopharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2019 Category: Pharmaceuticals Source Type: news

Rite Aid Shareholders Approve Plan To Avoid NYSE Delisting
Rite Aid shareholders Thursday approved a “reverse stock split” in an effort to keep the company’s stock from being delisted by the New York Stock Exchange. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Doctor App Babylon Health Offers Quick Appointments, But Grapples With Follow-Up Care For Mental Health
A third of London ’s mental-health providers are rejecting patient referrals from Babylon Health, a video-calling service used by thousands. Former staff say the startup is struggling to plug into Britain’s healthcare system. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Parmy Olson, Forbes Staff Source Type: news

Recall: Dollar General Baby Cough Syrup Can Cause Vomiting, Diarrhea
GOODLETTSVILLE, Tenn. (CBS) – A baby cough syrup sold nationwide at Dollar General stores is being recalled because it could cause vomiting and diarrhea. Kingston Pharma is recalling a lot of its DG/Health Naturals Baby Cough Syrup + Mucus because testing showed some bottles may be contaminated with Bacillus cereus or circulans, bacteria that can cause gastrointestinal illness. No ill effects have been reported in connection with the recalled cough syrup, but the bacteria has been known to trigger serious or even deadly illnesses. The recalled bottles are marked Lot KL180157 with an expiration date of 11/20 and UPC c...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 21, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News Cough Syrup Recall Source Type: news

Beckman Coulter's Compact, Low-volume Hematology Analyzer Receives FDA 510(k) Clearance
With just 17 microliters of blood, the DxH 520 enables low-volume laboratories to deliver 5-part differential test results in 60 seconds or less BREA, Calif., March 21, 2019 -- (Healthcare Sales & Marketing Network) -- Beckman Coulter, a global leader ... Devices, Diagnostics, FDA Beckman Coulter, DxH 520, hematology analyzer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2019 Category: Pharmaceuticals Source Type: news

Soliton Files 510(k) with FDA for its Rapid Acoustic Pulse Device
510(k) Application for Premarket Clearance filed with the FDA for Rapid Acoustic Pulse ("RAP") device in tattoo removal HOUSTON, March 21, 2019 -- (Healthcare Sales & Marketing Network) -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or... Devices, Dermatology, FDA Soliton , Rapid Acoustic Pulse, tattoo removal, Q-switched laser (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2019 Category: Pharmaceuticals Source Type: news

Mirum Pharmaceuticals Appoints Chris Peetz as Chief Executive Officer
Mike Grey to Remain with Mirum in Role of Executive Chairman FOSTER CITY, Calif., March 21, 2019 -- (Healthcare Sales & Marketing Network) -- Mirum Pharmaceuticals today announced the appointment of Chris Peetz as chief executive officer. The company's... Biopharmaceuticals, Personnel Mirum Pharmaceuticals, maralixibat, Alagille syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2019 Category: Pharmaceuticals Source Type: news

Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara(TM)
VANCOUVER, March 21, 2019 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technol... Devices, Interventional, Cardiology, Litigation Neovasc, Edwards Lifesciences, CardiAQ, Tiara , mitral bioprosthesis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2019 Category: Pharmaceuticals Source Type: news

Enzyvant's Investigational Farber Disease Enzyme Replacement Therapy, RVT-801, Receives FDA Fast Track and Rare Pediatric Disease Designations
CAMBRIDGE, Mass. and BASEL, Switzerland, March 21, 2019 -- (Healthcare Sales & Marketing Network) -- Enzyvant, a biopharmaceutical company focused on developing and commercializing transformative therapies for patients with rare diseases, today announced ... Biopharmaceuticals, FDA Enzyvant, Roivant Sciences, Farber Disease, enzyme replacement therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2019 Category: Pharmaceuticals Source Type: news

Three Factors Predict Psych Events With Drugs for Smoking Cessation
THURSDAY, March 21, 2019 -- Three factors predict clinically significant neuropsychiatric adverse events (NPSAEs) in smokers with or without mental health conditions who use cessation pharmacotherapy, according to a study published online March 7 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

In Youth With ADHD, New-Onset Psychosis Up With Amphetamines
THURSDAY, March 21, 2019 -- For adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD), new-onset psychosis occurs more often with amphetamine use versus methylphenidate use, according to a study published in the March 21... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

ACC: Robust Evidence Lacking for Many Cardiovascular Guidelines
THURSDAY, March 21, 2019 -- Only a small proportion of recommendations in major cardiovascular society guidelines are supported by evidence from multiple randomized controlled trials (RCTs) or a single large RCT, according to a study published in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Prevalence of Severe Maternal Morbidity Increased Across Groups
THURSDAY, March 21, 2019 -- From 1997 to 2014, there was an increase in the prevalence of severe maternal morbidity (SMM), with persistent racial/ethnic disparities, according to a study published online Feb. 28 in the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Digital Breast Tomosynthesis Can Reduce Benign Biopsy Rate
THURSDAY, March 21, 2019 -- Digital breast tomosynthesis (DBT) can reduce the rate of benign biopsies without affecting cancer detection compared with full-field digital mammography (FFDM), according to a study published online March 19 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Antibiotics, PPIs Tied to Higher C. Diff Risk in Hospitalized Children
THURSDAY, March 21, 2019 -- Previous antibiotic exposure and use of proton pump inhibitors (PPIs) may be risk factors for Clostridioides (formerly Clostridium) difficile infection (CDI) in hospitalized pediatric patients, according to a review... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Younger Female Blood Donors Vulnerable to Iron Deficiency
THURSDAY, March 21, 2019 -- Blood donation is associated with iron deficiency among both adolescent girls and younger adult women in the United States, according to a study recently published in Transfusion. Eshan U. Patel, M.P.H., from the Johns... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Statins Tied to Insulin Resistance, Higher Serum Fasting Insulin
THURSDAY, March 21, 2019 -- Individuals using statins may be at higher risk for hyperglycemia, insulin resistance, and eventually type 2 diabetes, according to a study published online March 5 in the British Journal of Clinical Pharmacology. Fariba... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Mothers of Children With Eczema More Likely to Have Exhaustion
THURSDAY, March 21, 2019 -- Mothers of children with atopic dermatitis (AD) are more likely to report difficulty falling asleep and daytime exhaustion, according to a study published online March 20 in JAMA Dermatology. Faustine D. Ramirez, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

Older Age at Puberty Linked to Lower Odds of Multiple Sclerosis
THURSDAY, March 21, 2019 -- Older genetically predicted age at puberty is associated with reduced odds of multiple sclerosis (MS), although the correlation seems to be dependent on body mass index (BMI), according to a study published online March... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news

New U.K. Partnership Aims To Improve Access Immunotherapy For Cancer Patients
A new genomics partnership fusing AI, liquid biopsy and a huge repository of genomic data aims to improve the prescription of immunotherapies for cancer patients in the U.K. Photo credit: Getty royalty-free (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Biogen to halt late-stage trial of promising Alzheimer’s drug
Decision by US biotech and Japanese partner sparks tumble in Biogen shares (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 21, 2019 Category: Pharmaceuticals Source Type: news

Atrium Health looks to build $18M satellite emergency department in Charlotte
Charlotte-based Atrium Health is planning for a freestanding emergency department to operate as an extension of its University City hospital. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2019 Category: Pharmaceuticals Authors: Caroline Hudson Source Type: news

Baptist Health to create 230 jobs at new facility in Broward
The outpatient center will offer primary care, diagnostic imaging, urgent care, multispecialty surgery, medical oncology, physical therapy and a spine care clinic. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2019 Category: Pharmaceuticals Authors: Brian Bandell Source Type: news

Pfizer secures exclusive option to acquire gene therapy company Vivet Therapeutics
PARIS & Vivet Therapeutics ("Vivet"), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc. (NYSE: PFE) announced that Pfizer has acquired a 15% equity interest in Vivet and secured an exclusive option to acquire all outstanding shares. (Source: World Pharma News)
Source: World Pharma News - March 21, 2019 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Florida Senate eyes hospital Medicaid payments
The Florida Senate wants to waive a requirement that the Legislature ratify medical marijuana rules. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2019 Category: Pharmaceuticals Authors: Christine Sexton Source Type: news

Columbus urologists land investment to build national mega-practice
Central Ohio Urology Group is on the hunt for affiliates. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2019 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news

With Launch Of New CRISPR Company, Competition Extends To Diagnostics
One of Sherlock Biosciences ’ key technologies comes from the Broad Institute lab of Feng Zhang, who did some of the early work elucidating the DNA-modifying potential of CRISPR and its associated enzymes after their discovery in bacteria. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Ellie Kincaid, Forbes Staff Source Type: news

Largest physical therapy facilities in the Wichita area
Source: Facility representatives. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2019 Category: Pharmaceuticals Source Type: news

Q & A: Head of Stream's health care division on assisted living facilities
The head of Stream Realty's new health care division talks assisted living facilities. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2019 Category: Pharmaceuticals Authors: Ryan Salchert Source Type: news

Ohio medical marijuana sales rise despite limited availability
The Ohio Department of Commerce said  residents have bought more than $2 million worth of medical marijuana in the first two months of sales, WVXU reports.  The nine medical marijuana dispensaries now open have sold 288 pounds of the product since the first day of sales on Jan. 16. The average price is nearly $472 per ounce. A t otal of 448 doctors have been given the green light to recommend marijuana. While 19,395 patients have registered for the program, only 5,465 of them have actually… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2019 Category: Pharmaceuticals Source Type: news

Addressing the pending shortage of dentists
A national shortage of dentists is looming, and is expected to be even worse here in New York. That's also true for teaching faculty at dental schools. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 21, 2019 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Bayer is taking collaboration with health care start-ups to the next level
As a pioneer when it comes to collaborating with digital health start-ups, Bayer is now taking the next step. Instead of one-off startup programs, it is now focusing on collaborating in specific digital health focus areas, e.g. digital therapeutics, AI for drug discovery, and patient engagement platforms to name a few. To do this, Bayer is combining the G4A programs and concentrating on longer-term collaborations and investments. (Source: World Pharma News)
Source: World Pharma News - March 21, 2019 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Preparing The Human Workforce For The Machine Workforce
As artificial intelligence-driven automation changes the nature of work and workplaces in unpredictable ways, how are nations shifting the way they think about the workforce? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Jayshree Pandya, Contributor Source Type: news

Monsanto risk takes root with Bayer investors
Doubts mount over $63bn takeover as worries over cost of glyphosate cancer link wipe €25bn from market value (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 21, 2019 Category: Pharmaceuticals Source Type: news

Sen. Kirsten Gillibrand Tweeted An Opioid Proposal: Here's The Reaction
Senators Kirsten Gillibrand and Cory Gardner " introduced legislation to limit opioid prescriptions for acute pain to 7 days. " (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Why Singapore's Wealthiest Are Backing This Lawyer In The Fight Against Childhood Cancer
Jennifer Yeo's overarching goal is to recreate the success of St. Jude ’s in Singapore, where it can serve as the hub for curing childhood cancer across the Asia-Pacific. Countries such as Cambodia and the Philippines will be able to tap into the resources rooted in current research findings. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Grace Chung, Forbes Staff Source Type: news

Johnson & Johnson Joins Forces with Monash University-led Partnership to Advance Novel Technology Aimed at Saving Lives of Women in Child Birth
(Source: Johnson and Johnson)
Source: Johnson and Johnson - March 21, 2019 Category: Pharmaceuticals Source Type: news